These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 33168076)
1. Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells. Shigesaka M; Ito T; Inaba M; Imai K; Yamanaka H; Azuma Y; Tanaka A; Amuro H; Nishizawa T; Son Y; Satake A; Ozaki Y; Nomura S Arthritis Res Ther; 2020 Nov; 22(1):264. PubMed ID: 33168076 [TBL] [Abstract][Full Text] [Related]
2. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells. Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398 [TBL] [Abstract][Full Text] [Related]
3. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389 [TBL] [Abstract][Full Text] [Related]
4. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus. Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y Front Immunol; 2018; 9():1957. PubMed ID: 30210502 [No Abstract] [Full Text] [Related]
5. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes. Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814 [TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Sacre K; Criswell LA; McCune JM Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582 [TBL] [Abstract][Full Text] [Related]
8. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Jin O; Kavikondala S; Mok MY; Sun L; Gu J; Fu R; Chan A; Yeung J; Nie Y; Lau CS Arthritis Res Ther; 2010; 12(4):R137. PubMed ID: 20618924 [TBL] [Abstract][Full Text] [Related]
10. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells. Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893 [TBL] [Abstract][Full Text] [Related]
11. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c Yim LY; Lau CS; Chan VS Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763 [TBL] [Abstract][Full Text] [Related]
12. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation. Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920 [TBL] [Abstract][Full Text] [Related]
13. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674 [TBL] [Abstract][Full Text] [Related]
15. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis. Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137 [TBL] [Abstract][Full Text] [Related]
16. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Amuro H; Ito T; Miyamoto R; Sugimoto H; Torii Y; Son Y; Nakamichi N; Yamazaki C; Hoshino K; Kaisho T; Ozaki Y; Inaba M; Amakawa R; Fukuhara S Arthritis Rheum; 2010 Jul; 62(7):2073-85. PubMed ID: 20506142 [TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638 [TBL] [Abstract][Full Text] [Related]
18. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells. Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146 [TBL] [Abstract][Full Text] [Related]
19. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297 [TBL] [Abstract][Full Text] [Related]
20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus. Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]